Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population

Chest

Volumn 142, Issue 2, 2012, Pages 358-366

  Nelson, Steven B ^a   LaVange, Lisa M ^b   Nie, Yonghong ^b   Walsh, John W ^c   Enright, Paul L ^d   Martinez, Fernando J ^e   Mannino, David M ^f   Thomashow, Byron M ^g  

^a American Association for Respiratory Care   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c COPD Foundation ^*  (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; FALSE NEGATIVE RESULT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MUCUS; PEAK EXPIRATORY FLOW; POCKET SPIROMETER; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOM SAMPLE; RISK ASSESSMENT; SCREENING; SENSITIVITY AND SPECIFICITY; SMOKING; SPIROMETER; SPIROMETRY; WHEEZING;

EID: 84864810561     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1474     Document Type: Article

References (41)

1. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD(the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-750.
2. The National Lung Health Education Program(NLHEP). Strategies in preserving lung health and preventing COPD and associated diseases. Chest. 1998;113(suppl 2):123S-163S.
3. Lusuardi M, De Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006;129(4):844-852.
4. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402-407.
5. Leuppi JD, Miedinger D, Chhajed PN, et al. Quality of spirometry in primary care for case finding of airway obstruction in smokers. Respiration. 2010;79(6):469-474.
6. U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(7):529-534.
7. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB; U.S. Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;148(7):535-543.
8. Qaseem A, Snow V, Shekelle P, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633-638.
9. Van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002;324(7350):1370.
10. Martinez FJ, Raczek AE, Seifer FD, et al; COPD-PS Clinician Working Group. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85-95.
11. Yawn BP, Mapel DW, Mannino DM, et al; Lung Function Questionnaire Working Group. Development of the Lung Function Questionnaire(LFQ) to identify airflow obstruction . Int J Chron Obstruct Pulmon Dis. 2010;5:1-10.
12. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ; COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6):1531-1539.
13. Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J. 2008;31(2):298-303.
14. Perez-Padilla R, Vollmer WM, Vázquez-García JC, Enright PL, Menezes AM, Buist AS; BOLD and PLATINO Study Groups. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis. 2009;13(3):387-393.
15. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
16. National Lung Health Education Program. Spirometer Review Process(SRP)-revised May 2008. Irving, TX: National Lung Health Education Program website. www.nlhep.org/spirometer-review-process.html. 2009. Accessed March 3, 2011.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179-187.
18. 1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest. 2005;127(5):1560-1564.
19. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease website. http://goldcopd.com/. Updated December 2010. Accessed March 3, 2011.
20. Peña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981-989.
21. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-946.
22. Castillo D, Guayta R, Giner J, et al; FARMAEPOC group. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med. 2009;103(6):839-845.
23. Tønnesen P, Carrozzi L, Fagerström KO, et al. Smoking cessa tion in patients with respiratory diseases: a high priority, inte gral component of therapy. Eur Respir J. 2007;29(2):390-417.
24. Buffels J, Degryse J, Decramer M, Heyrman J. Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med. 2006;100(11):2012-2017.
25. Wilt TJ, Niewoehner D, Kane RL, MacDonald R, Joseph AM. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res. 2007;9(1):21-32.
26. Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006;61(10):869-873.
27. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598-600.
28. Stratelis G, Mölstad S, Jakobsson P, Zetterström O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006;24(3):133-139.
29. Cooper BG. Limitations to spirometry being performed in 'the office'. Chron Respir Dis. 2005;2(2):113-115.
30. Enright P. Provide GPs with spirometry, not spirometers. Thorax. 2008;63(5):387-388.
31. Poels PJP, Schermer TRJ, Jacobs A, et al. Variation in spirometry utilization between trained general practitioners in practices equipped with a spirometer. Scand J Prim Health Care. 2006;24(2):81-87.
32. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403-409.
33. Zieliñski J, Bednarek M; Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001;119(3):731-736.
34. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood-Baker R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax. 2008;63(5):408-414.
35. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742-750.
36. Carvalhaes-Neto N, Lorino H, Gallinari C, et al. Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med. 1995;152(5 pt 1):1611-1615.
37. Bellia V, Pistelli R, Catalano F, et al. Quality control of spirometry in the elderly. The S.A.R.A. study. Am J Respir Crit Care Med. 2000;161(4):1094-1100.
38. Pezzoli L, Giardini G, Consonni S, et al. Quality of spirometric performance in older people. Age Ageing. 2003;32(1): 43-46.
39. 3 as an alternative to FEV 1 /FVC for patients with mild cognitive impairment. Clin Respir J. 2008;2(4):208-213.
40. Bellia V, Pistelli F, Giannini D, et al. Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients. Eur Respir J Suppl. 2003;40:21s-27s.
41. 1 are poorly correlated in an elderly population. Chest. 2007;131(5):1494-1499.